These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9591219)

  • 1. Multiple sclerosis: assessment of disability and disability scales.
    Thompson AJ; Hobart JC
    J Neurol; 1998 Apr; 245(4):189-96. PubMed ID: 9591219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring handicap in multiple sclerosis.
    Thompson AJ
    Mult Scler; 1999 Aug; 5(4):260-2. PubMed ID: 10467385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis?
    Merkelbach S; Sittinger H; Koenig J
    J Nerv Ment Dis; 2002 Jun; 190(6):388-93. PubMed ID: 12080209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of impairment in MS: discussion of the scales in use.
    Amato MP; Ponziani G
    Mult Scler; 1999 Aug; 5(4):216-9. PubMed ID: 10467378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychometric properties of clinical rating scales used in multiple sclerosis.
    Sharrack B; Hughes RA; Soudain S; Dunn G
    Brain; 1999 Jan; 122 ( Pt 1)():141-59. PubMed ID: 10050902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidimensional assessment of multiple sclerosis: relationships between disability domains.
    Provinciali L; Ceravolo MG; Bartolini M; Logullo F; Danni M
    Acta Neurol Scand; 1999 Sep; 100(3):156-62. PubMed ID: 10478578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impairment, disability and handicap scales in multiple sclerosis].
    Arbizu-Urdiain T; Martínez-Yélamos A; Casado Ruiz V
    Rev Neurol; 2002 Dec 1-15; 35(11):1081-93. PubMed ID: 12497316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS).
    Twork S; Wiesmeth S; Spindler M; Wirtz M; Schipper S; Pöhlau D; Klewer J; Kugler J
    Health Qual Life Outcomes; 2010 Jun; 8():55. PubMed ID: 20529265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
    Ayatollahi P; Nafissi S; Eshraghian MR; Kaviani H; Tarazi A
    Mult Scler; 2007 Mar; 13(2):275-7. PubMed ID: 17439899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis.
    Gavelova M; Nagyova I; Rosenberger J; Krokavcova M; Gdovinova Z; Groothoff JW; van Dijk JP
    Disabil Health J; 2015 Jul; 8(3):372-9. PubMed ID: 25981341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the international classification of functioning, disability and health to describe patient-reported disability: a comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort.
    Ng L; Khan F
    Disabil Rehabil; 2012; 34(4):295-303. PubMed ID: 21988084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.
    Janardhan V; Bakshi R
    Arch Neurol; 2000 Oct; 57(10):1485-91. PubMed ID: 11030802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The symptom inventory disability-specific short forms for multiple sclerosis: construct validity, responsiveness, and interpretation.
    Schwartz CE; Bode RK; Quaranto BR; Vollmer T
    Arch Phys Med Rehabil; 2012 Sep; 93(9):1617-1628.e1. PubMed ID: 22580198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.
    Amato MP; Ponziani G; Rossi F; Liedl CL; Stefanile C; Rossi L
    Mult Scler; 2001 Oct; 7(5):340-4. PubMed ID: 11724451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The symptom inventory disability-specific short forms for multiple sclerosis: reliability and factor structure.
    Schwartz CE; Bode RK; Vollmer T
    Arch Phys Med Rehabil; 2012 Sep; 93(9):1629-1636.e2. PubMed ID: 22446293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.
    Huda S; Cavey A; Izat A; Mattison P; Boggild M; Palace J
    J Neurol Sci; 2016 Mar; 362():66-8. PubMed ID: 26944120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
    Hohol MJ; Orav EJ; Weiner HL
    Mult Scler; 1999 Oct; 5(5):349-54. PubMed ID: 10516779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.